April 20, 2026 Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
April 20, 2026 NAVN Investors with Losses in Excess of $100K Have Opportunity to Lead Navan, Inc. Securities Lawsuit
April 20, 2026 EOSE Investors Have Opportunity to Lead Eos Energy Enterprises, Inc. Securities Fraud Lawsuit
April 20, 2026 Mabwell Passes On-site GMP Inspection by Regulatory Authority of PIC/S Member Country (Jordan) for the First Time
